Tilray | TRLY - Выручка от реализации





Продажи Изменить Дата
Acasti Pharma USD -4.76M 4.76M 2024-12
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alaunos Therapeutics USD 2K 2K 2025-03
Aurora Cannabis CAD 38.01M 56.18M 2026-03
Avita Medical AUD 17.61M 805K 2025-12
Canopy Growth CAD 71.25M 3.29M 2026-03
Cronos Group USD 53.01M 5.96M 2026-06
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 27.58B 730M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
IQVIA Holdings USD 4.37B 220M 2026-06
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Moderna USD 100M 289M 2026-06
Organigram Holdings CAD 59.79M 3.74M 2026-03
Organon & Co USD 1.56B 100M 2026-06
Revvity USD 729.68M 18.68M 2026-06
Tectonic Therapeutic USD 0 0 2024-12
Tilray USD 217.51M 74.75M 2025-12
Viatris USD 3.76B 240M 2026-06
Xeris Pharmaceuticals USD 83.13M 2.68M 2026-03
Zealand Pharma A/S 34M 34.92M 2026-03